作者:
Emma J,Groen [1]
;
Marieke E M,van der Noordaa [2]
;
Michael,Schaapveld [3]
;
Gabe S,Sonke [4]
;
Ritse M,Mann [5]
;
Mette S,van Ramshorst [6]
;
Esther H,Lips [7]
;
Marie-Jeanne T F D,Vrancken Peeters [8]
;
Frederieke H,van Duijnhoven [2]
;
Jelle,Wesseling [3]
作者单位:
Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
[1]
Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
[2]
Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
[3]
Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
[4]
Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
[5]
Department of Radiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
[6]
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
[7]
Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
[8]
Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. j.wesseling@nki.nl.
[9]
Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. j.wesseling@nki.nl.
[10]
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. j.wesseling@nki.nl.
[11]
主题词
乳腺肿瘤(Breast Neoplasms);癌, 导管, 乳腺(Carcinoma, Ductal, Breast);癌, 导管内, 非浸润性(Carcinoma, Intraductal, Noninfiltrating);女(雌)性(Female);人类(Humans);乳房切除术(Mastectomy);乳房切除术, 区段(Mastectomy, Segmental);肿瘤辅助疗法(Neoadjuvant Therapy)
DOI
10.1007/s10549-021-06235-2
PMID
33945043
发布时间
2022-02-18